The development of effective receptor-targeted nonviral vectors for use in vivo is complicated by a number of technical problems. One of these is the low efficiency of the conjugation procedures used to couple protein ligands to the DNA condensing carrier molecules. We have made and characterized a multi-domain protein (SPKR) 4 inv, that is designed to target plasmid DNA to ␤ 1 integrins in remodeling tissue. It contains a nonspecific DNA-binding domain (SPKR) 4 , a rigid ␣-helical linker, and the C-terminal ␤ 1 integrin binding domain (aa 793-987) of the Yersinia pseudotuberculosis invasin protein. (SPKR) 4 inv could be purified at high yields using a bacterial expression system. We show that (SPKR) 4 inv binds with high affinity to both plasmid DNA and ␤ 1 integrins. In a cell attachment assay, the apparent affinity of (SPKR) 4 inv for ␤ 1 integrins is three orders of magnitude
Introduction
Receptor-targeted nonviral vectors have great potential in gene therapy. [1] [2] [3] Delivery of the therapeutic gene through receptor-mediated endocytosis (RME), specifically into the appropriate cell type is the major advantage of such vectors. This approach generally involves coupling a ligand of a cellular receptor to a DNA binding element, usually a positively charged polymer such as poly-l-lysine, 4 or polyethylenimine. [5] [6] [7] The polymer serves several important purposes. It condenses the DNA to a size suitable for RME, and it plays a role in the escape from the endosomal compartment. Several examples of ligand-polymer conjugates have been described in the literature, featuring transferrin, 8, 9 asialoglycoprotein receptor ligands, 10 immunoglobulins, 11 or serpin. 2 Upon mixing the ligand-polymer conjugate with plasmid DNA, the two elements form a complex, which enters the cells by RME.
One of the receptor types that have been chosen to study targeted delivery of vectors is the integrin. 12, 13 Integrins are dimers of two complementary transmembrane proteins, ␣ and ␤ chain, which form a binding site for higher than that of the synthetic peptide integrin ligand RGDS. (SPKR) 4 inv-plasmid complexes are not active in an in vitro transfection assay. However, transfection efficiencies of plasmid complexes with a cationic lipid micelle (DOTAP/Tween-20) or a cationic polymer (polyethylenimine), are significantly increased in combination with (SPKR) 4 inv. (SPKR) 4 inv-mediated transfection can be inhibited by a soluble form of ␤ 1 integrin, which is evidence for its receptor specificity. In conclusion, (SPKR) 4 inv allows ␤ 1 integrin-specific targeting of plasmid-carrier complexes, while avoiding inefficient and cumbersome coupling chemistry. The modular design of the expression vector allows production of similar multi-domain proteins with a different affinity. The further development of such complexes for use in vivo is discussed. Gene Therapy (2000) 7, 1505-1515. extracellular ligands. The ligand specificity is determined by the particular combination of ␣ and ␤ chains. Integrins are ubiquitously expressed by many cell types and are usually associated with matrix proteins in the basal region of polarized cells. However, these interactions are dynamic, in particular during migration and repair of damaged tissue. The intracellular integrin domains interact with signalling pathways that affect cellular motility and growth. Its affinity for an extra-cellular substrate depends on its state of conformational activation. Tumours have been successfully imaged with 99 Tc-labelled integrin-binding peptides, 14 indicating a significantly increased availability of integrins in this tissue. Apical expression of ␤ 1 integrins has been observed on epithelial cells during inflammation, wound healing and ischaemia. [15] [16] [17] Endothelial cells also express apical ␤ 1 integrins, which are involved in interactions with leukocytes when activated during the process of inflammation. 18 In conclusion, ␤ 1 integrins are available to external ligands, especially during clinically relevant conditions. This makes them an interesting target for vector delivery.
Several pathogens, including viruses and bacteria use integrin receptors to invade their target cells. One of these is Yersinia pseudotuberculosis, which makes the outermembrane protein invasin. This protein binds with high affinity to ␤ 1 -type integrins and thus mediates phagocytosis of the bacteria. The integrin-binding property resides in the carboxy-terminal part of the protein, in particular the terminal 192 amino acid loop structure. 19 This protein domain can be used to induce uptake of material by integrin-expressing cells, 20 as an alternative to synthetic peptides. Peptides that contain the integrinbinding RGD amino acid motif substantially improve transfection efficiency in vitro, when coupled chemically to a cationic polymer. 21, 22 However, proof that such preparations are able to deliver DNA efficiently to integrin exposing cells in vivo has not been presented yet. Major problems in the formulation of a compound that can be used systemically are caused by nonspecific interactions with blood components, and the tendency of the complexes to dissociate or aggregate. Moreover, chemical coupling of a ligand to a polymer is generally inefficient, difficult to reproduce, and results in a random conjugation product. An alternative is to combine the DNA binding and ligand elements in a single modular recombinant protein. Examples of such recombinant multidomain proteins have been described, 23 ,24 using a DNAbinding domain that binds to a specific-sequence on the DNA vector. A fusion protein of the integrin binding sequence of invasin with a sequence-specific DNA-binding domain enhances the transfection efficiency in vitro, when combined with polylysin and chloroquin. 24 In the present study, we describe the production in a bacterial expression system, and functional characterization of a novel modular protein, (SPKR) 4 inv, designed to mediate integrin-targeted gene delivery. (SPKR) 4 inv spontaneously associates with plasmid DNA and binds to cellular integrins with high affinity. In combination with a cationic liposome (DOTAP) or a cationic polymer (PEI), efficient expression of marker gene in different cell lines was achieved. Our data suggest that this modular fusion protein system can be used as part of a gene delivery system targeted to cells exposing ␤ 1 -integrin receptors.
Results

Construction of expression plasmids
The (SPKR) 4 inv protein ( Figure 1 ) contains three functional domains. First, a non-specific DNA-binding domain, (SPKR) 4 , which is derived from the histone H1. 25 This sequence is able to condense plasmid DNA upon binding to the minor groove. In a previous article, we have shown that a synthetic peptide with this sequence, in combination with a lysogenic peptide, can be used as an efficient transfection agent. 26 Second, a rigid ␣-helical linker domain, 27 flanked by flexible proline-glycine sequences, which separates the DNA-binding and receptor-binding elements. This should allow independent action of the two domains. As the integrin targeting element of the protein, the C-terminal domain (aa 793-987) of the invasin protein from Yersinia pseudotuberculosis was used. 19 The DNA fragment encoding amino acids 793-987 of the Yersinia pseudotuberculosis invasin protein, the ␣-helical linker and the DNA-binding (SPKR) 4 domain, were cloned into the inducible bacterial expression vector pET30a, to obtain the pET30a-(SPKR) 4 inv expression vector, as described in the Methods section. The complete (SPKR) 4 inv protein sequence includes an amino-terminal poly-histidine for Ni-NTA affinity column purification, an S-tag peptide for detection on Western blot, and two protease sites for Tag Figure 1 Protein sequence and structure of (SPKR) 4 removal ( Figure 1 ). The 22 amino acid linker is a modification of the sequence published by Gong et al. 27 An extra N-terminal proline in the linker domain and glycine residues N-and C-terminal to the linker were included, to allow unrestrained movement of the (SPKR) 4 and inv domains. The pET30a-inv construct, which lacks both the linker and DNA-binding domains, was obtained by cloning the invasin sequence as an EcoRI/EcoRI fragment into the pET30a vector.
Bacterial expression of the recombinant proteins
The recombinant proteins were produced in E. coli strain HMS174 (DE3/lysS), which allows tight transcriptional control of the pET30a vector by IPTG induction. At 37°C, the (SPKR) 4 grown at 20°C, part of the total protein was produced in soluble form, of which about 0.5 mg could be recovered from a Ni-NTA affinity column per liter of culture. After further purification by FPLC chromatography the yield was approximately 100 g per liter of culture. To improve the yield and purity of the produced proteins, another purification method was used, in which insoluble proteins are dissolved and denatured in Guanidin-HCl (see Materials and methods). 24 Purification of (SPKR) 4 inv and inv on a Ni-NTA affinity column in the presence of urea yielded 10-15 mg of partially purified proteins per liter of bacterial culture (Figure 2a) . Refolding of the denatured proteins was achieved by stepwise decrease of the urea concentration by dialysis. 24 Under these conditions, about half of the protein was recovered in soluble form. After further purification by FPLC chromatography, a yield of 5-7.5 mg protein per liter of bacterial culture was obtained. As expected, (SPKR) 4 inv and inv have an apparent molecular weight of 33 000 and 32 000, respectively ( Figure 2a ).
(SPKR) 4 inv binds to plasmid DNA The DNA binding activity of the (SPKR) 4 domain was assessed in a retardation assay. In the presence of (SPKR) 4 inv protein, the two plasmid DNA bands (supercoiled and relaxed) showed a different migration pattern at all protein concentrations tested ( Figure 3a , lanes 1-4), whereas inv protein at comparable concentrations had no effect on plasmid mobility (Figure 3a , lanes 5-7). Atomic force microscopy revealed that (SPKR) 4 inv induces partial condensation of plasmid DNA (Figure 3b ). These data show that the DNA-binding domain in (SPKR) 4 inv is functional.
(SPKR) 4 inv binds to ␤ 1 integrins with high affinity The 192 amino acid C-terminal domain from the Yersinia pseudotuberculosis invasin protein was shown to be necessary and sufficient to bind a variety of ␤ 1 -type integrins on the mammalian cell surface. 19 The ability of the (SPKR) 4 inv fusion protein to bind to cells was tested with a filter overlay assay. 28 Proteins were subjected to SDS-PAGE, transferred to a nitrocellulose membrane and exposed to a suspension of HEp-2 cells, which are known to express ␤ 1 integrins. The presence of cell-binding proteins on the filter is detected by staining the cells with Amido black. Both (SPKR) 4 inv and inv proteins immobilized to a nitrocellulose filter bind to HEp-2 cells ( Figure  2b) . The protein-cell interaction is only maintained in SDS-PAGE sample buffer at 37°C but it is lost at 100°C (Figure 2b ). Moreover, a temperature-dependent shift of protein mobility was observed in the Coomassie-stained gel, which confirms that a conformation change occurs ( Figure 2a ). In addition, the S-tag becomes available for the staining reaction only after boiling the proteins in sample buffer (Figure 2c ). These results show the capacity of the partially denatured, but not the fully denatured inv-containing recombinant proteins produced in a bacterial expression system to bind integrin-expressing cells.
The invasin C-terminus binds to cells by a specific interaction with the ␤ 1 chain of integrins 29 including the ␣ 5 ␤ 1 fibronectin receptor. 30 In order to demonstrate that the recombinant (SPKR) 4 inv protein binds with high affinity to ␤ 1 integrins, its capacity to interfere with the binding of cells to fibronectin was evaluated in a quantitative attachment assay (see Methods section). HEp-2 cells, which express the ␣ 5 ␤ 1 integrin, bind efficiently to fibronectin-coated wells, but not to uncoated wells. In contrast, the HT29 cell line, which does not express ␣ 5 ␤ 1 integrin, 31 has a low capacity to bind (Fortunati, unpublished data). Pre-incubation of HEp-2 cells with increasing amounts of (SPKR) 4 inv caused a significant inhibition of the binding efficiency ( Figure 4 ). This is evidence for an interaction between the major fibronectin receptor (␣ 5 ␤ 1 integrin) and (SPKR) 4 inv, as observed previously for the intact invasin protein. 29 As a measure of its binding affinity we calculated the concentration of (SPKR) 4 inv protein that reduces the cell binding to fibronectin coated-wells with 30% (ID 30 ) (Table 1) , from a doseresponse curve as shown in Figure 4 . The result, 120 nM, is comparable to that obtained with a monoclonal antibody (CD49e) that specifically recognizes the ␣ 5 sub-unit of the human ␣ 5 ␤ 1 integrin (Table 1) . In contrast, a peptide (RGDS) containing the integrin-binding RGD motif, 32 which has frequently been used for integrin targeting of vectors, 21, 22, 33 had an ID 30 that was three orders of magnitude higher than (SPKR) 4 inv. This shows that (SPKR) 4 inv binds to its target with much higher affinity than the peptide RGDS. When (SPKR) 4 inv was used to coat the wells, the HEp-2 cells bind efficiently, compared with uncoated wells. For inhibition of cell attachment on (SPKR) 4 invcoated wells, more antibody against the ␣ 5 integrin subunit (CD49e) was needed than on fibronectin (Table 1) . This may be due to the fact that (SPKR) 4 inv also interacts with other members of the ␤ 1 integrin family. In strong support of these data, a soluble form of recombinant ␣ 3 ␤ 1 integrin 34 effectively inhibited the binding of HEp-2 cells to (SPKR) 4 inv-coated wells at low concentrations (Table  1) , which is further evidence for the specificity of the Table 1) . In summary, these data show that the inv-containing fusion proteins are active in binding to ␤ 1 integrins, in particular ␣ 5 ␤ 1 and ␣ 3 ␤ 1 , with an affinity that is comparable to a monoclonal antibody, and much higher than an RGD peptide. The results shown here were achieved with proteins made with the renaturation method. Proteins isolated from the soluble fraction gave comparable results (not shown).
(SPKR) 4 inv increases the transfection efficiency of a endosomolytic compound (SPKR) 4 inv-plasmid complexes do not efficiently transfect cells in vitro ( Figures 5 and 6 ). Transfection in the presence of chloroquin does increase transfection efficiency, albeit to a low level (data not shown). This is not surprising, since (SPKR) 4 inv, which was designed as a targeting device, has neither a strong DNA condensing nor an endosomolytic capacity, both important properties of synthetic transfection systems. Therefore, we studied combinations of (SPKR) 4 inv and cationic carriers to arrive at an effective integrin-targeted formulation. First, the cationic DOTAP liposome was tested as helper agent. When DOTAP was added to (SPKR) 4 inv/DNA complexes that were solubilized in a binding buffer containing 0. Gene Therapy 4 In another series of experiments, the cationic polymer polyethylenimine (PEI), which is a simple and effective transfection agent [5] [6] [7] was used as a endosomolytic and DNA condensing helper substance. Plasmid DNA, complexed to (SPKR) 4 inv and control, was mixed with different amounts of PEI, and the complexes were used to transfect HeLa cells ( Figure 6 ). The data show that DNA/(SPKR) 4 inv/PEI complexes consistently give a considerably (four-to 10-fold) higher marker gene expression than DNA/PEI alone. These data were confirmed in four similar, independent titrations. The loss 4 of activity at high PEI/DNA ratios ( Figure 6 ) could be attributed to toxicity of the PEI, as shown by a strong reduction of the protein recovery (data not shown). Variation of the amount of (SPKR) 4 inv resulted in an optimal weight ratio under these conditions (DNA:protein:PEI) for maximal luciferase expression of 1:1:3 (not shown). Addition of fetal calf serum during transfection did reduce the marker gene expression of both PEI and (SPKR) 4 inv/PEI complexes, but not the stimulatory effect of (SPKR) 4 inv ( Figure 7) . The difference between DNA/(SPKR) 4 inv/PEI and DNA/PEI complexes was actually greatest at high (10%) serum concentrations. The total luciferase activity obtained depended strongly and in a nonlinear way on the amount of (SPKR) 4 inv/PEI and PEI complexes added per well (Figure 8 ).
Figure 5 Transfection efficiency of plasmid-(SPKR)
These data show that (SPKR) 4 inv, in combination with a carrier that has DNA-condensing and endosomolytic properties, promotes transfection efficiency in vitro.
The recombinant protein-mediated gene transfer is integrin specific The target specificity of (SPKR) 4 inv-mediated gene transfer was investigated using soluble ␣ 3 ␤ 1 recombinant integrin as a competitor. Pre-incubation of a DNA/ (SPKR) 4 inv/PEI transfection mixture with different amounts of recombinant ␣ 3 ␤ 1 for 30 min at room temperature, resulted in a marked reduction in marker gene expression after transfection of HeLa cells (Figure 9 ). In contrast, the efficiency of the DNA/PEI preparation was not significantly affected. These data support the conclusion that (SPKR) 4 inv is capable of targeting DNA specifically to ␤ 1 integrins, in the presence of PEI. A simi- 
Figure 8 Marker gene expression depends on the amount DNA complex per well. Transfection of HeLa cells with different amounts (ng DNA per well, containing 3 × 10 4 cells) of DNA/(SPKR) 4 inv/PEI (1:1:3, w:w, black bars), or DNA/PEI (1:3, w:w, open bars). The transfection experiment was performed as described in the legend of Figure 6. Bars represent averages of four independent values, error bars indicate standard error of the mean. The difference between complexes with or without (SPKR) 4 inv is statistically significant (t test, *P Ͻ 0.005), reduction of the amount of complex per well significantly reduces the marker gene expression (#P Ͻ 0.001).
lar result was obtained with DNA/(SPKR) 4 inv/DOTAP complexes ( Figure 10 ).
Discussion
We set out to investigate whether it is feasible to target plasmid DNA complexes to a cellular receptor with a multi-domain protein that contains a nonspecific DNAbinding protein. This approach would allow us to introduce a receptor binding element to transfection com- 4 plexes without the need of chemical coupling, which is generally a tedious and inefficient procedure leading to random products. In addition, it would enable us to use a mixture of ligands in a simple way. This is expected to increase greatly the selectivity for a cell type that exposes Gene Therapy a particular combination of receptors. For this purpose, the (SPKR) 4 inv fusion protein was designed to have two independent functional domains, separated by a rigid ␣-helical linker (Figure 1) . One domain is a nonspecific DNA binding sequence (SPKR) 4 , derived from an H1 histone that is involved in sperm chromatin condensation. 25 We have shown previously that this sequence can be used in a DNA delivery system. 26 The other element is the amino-terminal domain from the Yersinia pseudotuberculosis invasin protein, which is known to bind ␤ 1 integrins with high affinity. 19, 20, 35, 36 The (SPKR) 4 inv protein and the inv protein, which lacks the DNA binding domain, were produced in a commercially available bacterial expression system. Both proteins could be recovered at high yields from the denatured bacterial lysate after renaturation by controlled dialysis, and purified in an active form by Ni-affinity and FPLC column chromatography (Figure 2) .
) inhibits the transfection efficiency of (SPKR) 4 inv/PEI-mediated transfection. HeLa cells were transfected with DNA/(SPKR) 4 inv/PEI complexes (1:1:3, black bars), or DNA/PEI complexes (1:3, open bars) as described in the legend of Figure 6, except that the complexes were incubated for 30 min with different amounts of soluble
␣ 3 ␤ 1 integrin, 34 as indicated (g ␣ 3 ␤ 1 per g DNA),
before dilution in medium. Bars represent averages of four values, error bars indicate standard error of the mean. The difference between complexes with and without (SPKR) 4 inv is significant (#P Ͻ 0.05). The effect of soluble integrin on transfection efficiency of (SPKR) 4 inv-containing, but not control complexes is significant (*P Ͻ 0.05, **P Ͻ 0.02, comparing the data groups plus and minus integrin P Ͻ 0.01).
Figure 10 Soluble integrin (␣ 3 ␤ 1 ) inhibits the transfection efficiency of (SPKR) 4 inv/DOTAP-mediated transfection. HEp-2 cells were transfected with DNA/(SPKR)
Retardation experiments and atomic force microscopy confirmed the expected binding affinity of (SPKR) 4 inv for plasmid DNA, in contrast to the inv protein ( Figure 3 ). Cells that express ␤ 1 integrins bind to (SPKR) 4 inv and inv in a blot overlay assay (Figure 2 ). This property is lost when the proteins are completely denatured in SDS (Figure 2) , showing that the capacity of the recombinant proteins to interact with cells is completely dependent on their correct conformation, as described previously for the complete invasin protein. 19 We were further able to show that the recombinant invasin proteins bind specifically and with high affinity to ␤ 1 integrins using a quantitative cell attachment assay ( Figure 4 , Table 1 ). A monoclonal antibody (CD49e) against the ␣ 5 sub-unit of the major ␣ 5 ␤ 1 fibronectin receptor interfered effectively with cell binding to a fibronectin-coated surface (SPKR) 4 inv had the same effect, when molar concentrations in the same range were used (Table 1) . Similarly, binding of cells to a (SPKR) 4 inv-coated surface was inhibited by the CD49e antibody. Most significantly, a soluble form of ␣ 3 ␤ 1 integrin 34 inhibited cell binding to (SPKR) 4 inv at nanomolar concentrations (Table 1 ). These data show that the renatured multi-domain protein (SPKR) 4 inv interacts at high affinity with ␤ 1 integrins as was demonstrated previously for invasin. 19, 20, 36 The apparent affinity of (SPKR) 4 inv for its target receptor in this assay was three orders of magnitude higher than that of a commercially available small peptide ligand of ␤ 1 integrins (RGDS). This could prove an important advantage of the invasin domain in ␤ 1 integrin-targeted compounds, compared with the synthetic peptide ligands. The S-tag (Figure 1) , is apparently not exposed in partially denatured (SPKR) 4 inv and inv, since it is only detected on Western blot when the samples are completely denatured ( Figure  2 ). This suggests that the tag is involved in an intra-molecular interaction that prevents binding of the probe. This could explain why it proved difficult to remove the tag from the native proteins by treatment with enterokinase (data not shown). Since the Tag does not interfere with either the DNA-or integrin-binding capacity of the proteins, the complete proteins were used in the experiments presented here.
To demonstrate that (SPKR) 4 inv can be used as a targeting device in combination with a DNA condensing and endosomolytic carrier, a series of transfection experiments was performed with cells known to express ␤ 1 integrins. We observed that (SPKR) 4 inv alone was unable to transfect cells, but significantly increased transfection efficiency of both DOTAP and PEI complexes (Figures 5  and 6 ). As expected, the DNA/protein ratio that was found to be effective in transfection experiments ( Figures  5 and 6 ) does not result in complete plasmid DNA retardation or condensation (Figure 3 ). This is evidence for a residual negative surface charge of the complexes, which would allow binding of a cationic carrier such as DOTAP or PEI. This, in turn, is required to allow efficient escape of the DNA from the lysosomal compartment.
Pre-incubation of (SPKR) 4 inv containing DOTAP and PEI complexes with a soluble form of ␣ 3 ␤ 1 integrin significantly reduced their transfection efficiency (Figures 9  and 10 ). This is not due to nonspecific interactions since 1% serum (800 g/ml protein) does not significantly inhibit the transfection efficiency of (SPKR) 4 inv/PEI complex ( Figure 7) . Moreover, PEI/DNA complexes are not significantly affected by soluble integrin (Figure 9 ). This shows that transfection with (SPKR) 4 inv-containing compounds is indeed integrin mediated under these conditions. An alternative way to show integrin specificity would be to study competition with soluble integrin ligands. However, incubation of the cells with appropriate concentrations (ϾID 30 , Table 1 ) of RGDS, inv or CD49e during transfection, resulted in significant changes in cell morphology and detachment from the matrix. This is likely due to interference with integrinmatrix interaction. Furthermore, integrin ligands are known to affect the physiology of the cells through activation of intracellular protein kinases. This effect introduces a bias in transfection experiments that cannot be corrected for by controls such as nonspecific antibody, which do not elicit this effect. Therefore, we must conclude that this approach does not lead to valid results in this experimental system.
Increasing the transfection efficiency of the receptormediated DNA complexes by addition of a cationic lipid has been shown previously. 21, 37 The lipid is likely to be involved both in DNA condensation and in the escape of the complexes from the lysosomal compartment. Optimal conditions for selective integrin-directed transfection involves an amount of liposome per DNA that is insufficient by itself, but effective in the presence of integrintargeted protein ( Figure 5 ). During our titration experiments we were able to create such conditions using mixed micelles of DOTAP and Tween-20, a non-ionic detergent with a low critical micelle concentration. Similarly, a mixed complex of plasmid DNA, (SPKR) 4 inv and the cationic polymer PEI proved to be more effective in transfection than DNA/PEI complexes that were made under the same conditions ( Figure 6 ). The role of PEI in the mixed complexes is expected to be comparable to that of DOTAP, ie DNA condensation and promoting escape from the lysosomal compartment. Addition of fetal calf serum in the transfection medium reduced the marker gene expression but did not abolish the stimulatory effect of (SPKR) 4 inv (Figure 7 ). This indicates that such a formulation could be effective in vivo. However, interaction with serum components is not the only issue. Titration of the amount of PEI showed an optimum (Figure 6 ), suggesting that a minimal amount of PEI was required to obtain efficient transfection, whereas higher amounts proved toxic to the cells. In addition, one of the most important determinants of transfection efficiency in the titration experiments proved to be the amount of complexed DNA per cell (Figure 8 ). The apparent non-linearity of this relationship also suggests that deposition of a minimal amount of endosomolytic carrier per cell is required to allow efficient escape from the endosomal compartment. This should be kept in mind when developing targeted gene transfer systems for use in vivo. Selective uptake is only useful when combined with efficient endosomal escape. On the other hand, the endosomolytic capacity of the carrier should not lead to toxicity. Furthermore, the cationic carrier is likely to contribute significantly to nonspecific uptake of complexes by the cells, and it should therefore be minimized. It is thought that much of the success in vitro, and lack of efficiency in vivo, of conventional cationic carrier systems depends on the positive surface charge of the complexes. This results in binding to the negatively charged plasma membrane promoting uptake, but also reduces the biological half-time and delivery to target cells of the complex. 9 Reduction of the surface charge to zero or negative values would solve this problem. This can be achieved by shielding of the surface charge by coating the complexes with poly-ethylenglycol (PEG).
9 Therefore, further improvements of the integrin-targeted delivery system described in this paper can be expected from the development of novel PEGylated carriers that allow efficient endosomal escape while reducing nonspecific interactions.
In conclusion, (SPKR) 4 inv is a novel multi-domain protein that binds both DNA and ␤ 1 integrins. In combination with a endosomolytic poly-cation, (SPKR) 4 inv it is able to transfect cells in vitro in a ␤ 1 integrin-dependent way. ␤ 1 Integrin targeting ligands have been used successfully in vitro, when coupled chemically to a cationic polymer. 22, 33 However, we show here that (SPKR) 4 inv binds to ␤ 1 integrins with a much higher affinity than the available RGD-type peptide ligands. In addition, the DNA binding domain of the protein makes inefficient and tedious coupling procedures unnecessary. Moreover, the modular design of the pET30a (SPKR) 4 inv expression vector allows the introduction of an alternative ligand by a simple cloning procedure. Another advantage of this chimaeric protein is that it will bind to any DNA expression vector, in contrast to a similar protein with a specific (Gal4) DNA-binding domain. 24 As noted in the introduction, integrins offer possibilities for in vivo targeting of damaged or inflamed tissues, 12,15-17 or tumours.
14 Future studies will be aimed at in vivo delivery of (SPKR) 4 inv and related proteins in vivo, in combination with novel PEGylated polycations with 'stealth' characteristics. + supplemented with 10% fetal calf serum, 2 mm glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin.
Cloning and expression vectors
The (SPKR) 4 DNA-binding sequence derived from the H1B histone 25, 26 was inserted into the pET-30a bacterial expression vector (Novagen, Madison, WI, USA), digested with NcoI and BamHI, by ligation of annealed double-stranded oligonucleotides (5Ј-CATGGCC(AGCC CAAAACGC) 4 GG-3Ј, 5Ј-GATCCC(GCGTTTTGGGCT) 4 GGC-3Ј). This results in an in-frame fusion of the DNA binding motif to six repeated histidine residues (His-tag) and a (S-tag) motif, which allow easier purification and a fast identification of the produced recombinant protein, respectively ( Figure 1 ). Next, a 71 bp double-stranded oligonucleotide encoding an ␣-helix peptide linker 27 was ligated as BamHI/EcoRI fragment into the pET30a-SPKR plasmid. The plasmid was sequenced and no mutations were found.
The DNA sequence of the invasin gene corresponding to amino acids 793-987 of the published sequence, 19 was amplified by PCR from Yersinia pseudotuberculosis chromosomal DNA (RIVM, Bilthoven, The Netherlands). The primers (Eurogentec, Seraing, Belgium) used for the PCR reaction were 5Ј-ATTCCCGGTACCTACGC-3Ј and 5Ј-GAATGCTATATTGACAGCG-3Ј. The PCR fragment was cloned first into an AT vector (Dr B Beverloo, Erasmus University, Rotterdam, The Netherlands), and then transferred as an EcoRI fragment into the pET30a-SPKR-linker vector, 3Ј to the linker sequence. The resulting plasmid (pET30a-(SPKR) 4 inv), encodes the (SPKR) 4 inv protein (Figure 1 ). The last cloning step resulted in addition of four extra amino acids (EFGL), 3Ј to the linker sequence (Figure 1 ). DNA sequencing identified seven point mutations in the invasin domain compared with a sequence previously published. 19 Four were silent mutations and the others resulted in amino acid changes: R→T (position 895), Q→V (position 971), P→Q (position 972). None of these mutations affect sequences known to be critical for integrin binding, 19 which is confirmed by our data ( Table 1, Figures 2 and 4) . The plasmid pET30a-inv, encoding the invasin domain aa 793-987, which lacks the DNA-binding and linker domains, but includes the Tag sequence was obtained by ligation of the EcoRI invasin domain fragment into the pET30a vector. The invasin domain sequence of the resulting plasmid was identical to the one in pET30a-(SPKR) 4 inv.
Bacterial expression and purification of the recombinant proteins
First method: production of soluble proteins: Log-phase cultures of E. coli, strain HMS174(DE3/LysS) carrying the plasmid pET30a-(SPKR) 4 inv, or pET30a-inv were grown to OD 600 of 0.9 at 20°C in Luria-Bertani medium supplemented with 30 g/ml kanamycin (Gibco, Breda, The Netherlands) and 34 g/ml chloramphenicol (Fluka, Zwyndrecht, The Netherlands). The expression of the recombinant proteins was induced by the addition of 1 mm isopropyl-␤-d-thiogalactopyranoside (IPTG; SigmaAldrich, Zwyndrecht, The Netherlands). The cells were harvested by centrifugation 3 h after IPTG induction, and stored at −20°C. The frozen pellet was resuspended in buffer A: 20 mm Tris-HCl pH 7.9, 1 m NaCl, 2 mm imidazole, 10% glycerol, 0.1% Tween-20 and 0.1 mm phenylmethyl-sulphonyl-fluoride (PMSF; Sigma-Aldrich), and lysed by sonication on ice. The cell lysate was cleared by centrifugation (10 000 g 30 min at 4°C) and loaded on to Gene Therapy Ni-NTA resin (Quiagen, Leusden, The Netherlands) which was previously equilibrated in buffer A. The column was washed with 10 column volumes of buffer B (20 mm Tris-HCl pH 7.9, 0.5 m NaCl, 20 mm imidazole 10% glycerol, 0.1% Tween-20 and 0.1 mm PMSF). Recombinant proteins were eluted with a 10 column volume linear gradient of imidazole (20-600 mm) in buffer B. The eluted fractions were analyzed by SDS gel electrophoresis, the recombinant proteins were identified on Western blot using the S-tag system (Novagen, R&D Systems Europe Ltd, Abingdon, UK). The method is based on the specific binding between the S-protein, conjugated to alkaline phosphatase, and the 15 amino acid S-tag peptide of the recombinant proteins. The fractions containing recombinant proteins were pooled and dialyzed to buffer C (20 mm Tris, 100 mm NaCl, 10% glycerol, 0.1% Tween-20, pH 7.9), further purified using an FPLC liquid chromatography device (Pharmacia, Uppsala, Sweden), on a MonoQ (inv) or MonoS column (SPKR 4 inv) equilibrated with buffer C and eluted with a linear NaCl gradient. In both cases the proteins eluted at about 250 mm NaCl.
Second method: purification of denatured recombinant proteins and renaturation by dialysis: The procedure followed is as published in Paul et al, 24 with minor modifications. The transformed bacteria were grown at 37°C, and harvested 3 h after induction, as described above. The frozen bacterial pellet of 0.5 l culture was dissolved in 20 ml 6 m guanidin-HCl, 0.5 m NaCl, 20 mm NaPO 4 , pH 7.8, sonicated, and centrifuged to clarity (10 000 g, 10 min). The supernatant was loaded on a 5 ml Ni-NTA affinity column equilibrated with buffer D: 6 m urea, 0.5 m NaCl, 20 mm NaPO 4 , pH 7.8. The column was washed with 10 volumes of buffer D. The recombinant proteins were eluted with a pH gradient (7.8-3.5) in buffer D. Fractions containing recombinant proteins were dialyzed overnight against buffer E (6 m urea, 20 mm Tris-HCl pH 7.5, 0.1 m NaCl, 10% glycerol, 5 mm ␤-mercaptoethanol, 0.1% Tween-20). Renaturation of the proteins was achieved by stepwise removal of urea by dialysis. Eight two-fold dilutions of the dialysis buffer with urea-free buffer E were performed at 2 h intervals, at 4°C. Tween-20 was added during the renaturation procedure to prevent precipitation due to hydrophobic interactions. 24 However, we have found that functional (SPKR) 4 inv could be renatured with the same efficiency in the absence of Tween-20. After removing precipitates by centrifugation, the proteins were purified on a mono-Q (inv) or mono-S ((SPKR) 4 inv), FPLC column. Peak fractions were concentrated to 0.2 g/l with a Centricon-10 centrifugal concentrator (Amicon, Beverly, MA, USA).
DNA retardation assay 0.25 Micrograms of plasmid DNA (pCMVGFP) was incubated with increasing amounts of SPKR 4 inv protein per 20 l DNA binding buffer (10 mm Tris-HCl pH 7.5, 100 mm NaCl, 10% glycerol, 0.01% Tween-20) for 30 min at room temperature. The samples were analyzed on a 1% agarose gel in Tris-Acetate-EDTA (TAE), stained with ethidium bromide.
Atomic force microscopy DNA samples and DNA protein complexes were prepared in binding buffer as described above, and subsequently diluted 10-fold in 5 mm Hepes, 2 mm MgCl 2 , pH 7.4. Twenty microliter samples were deposited on mica. After 1 min the mica was washed with HPLC grade water (Sigma-Aldrich), and dried in a stream of filtered air. Images were acquired on a Nanoscope IIIa (Digital instruments, Santa Barbara, CA, USA) operating in tapping mode in air, using Nanoprobe Silicon tips (Digital Instruments).
Cell binding to filter-immobilized recombinant proteins
The assay was performed according to Leong et al, 28 with minor modifications. The samples containing the recombinant proteins were loaded on a 11% SDS-PAGE gel and run at low voltage to avoid heating of the samples. Proteins were subsequently transferred to nitrocellulose filters (Ba85; Schleicher & Schuell, Dassel, Germany) by Western blotting. To avoid nonspecific protein binding, filters were pre-incubated overnight at 4°C in phosphatebuffered saline plus 10 g/l bovine serum albumin (BSA). HEp-2 cells were trypsinized, washed in medium containing 1 mg/ml soybean trypsin inhibitor (type I-S; Sigma-Aldrich) and resuspended in medium supplemented with 20 mm Hepes pH 7.4 and 4 g/l BSA, at a concentration of 10 6 cells/ml. The filters were incubated with 10 ml of this cell suspension at 37°C for 1 h. After washing three times in PBS, the filters were fixed with 3% (w/w) para-formaldehyde in PBS for 10 min at 20°C, stained with 1% Amido-black in 40% methanol, 10% acetic acid, and destained with 40% methanol, 10% acetic acid.
Cell attachment to coated wells Cells were harvested with trypsin-EDTA and resuspended in medium containing soybean trypsin inhibitor. After centrifugation, the cell pellet was resuspended in medium containing 20 mm Hepes pH 7.5, 4 g/l BSA. For inhibition studies, 3 × 10 4 cells were incubated with increasing concentrations of SPKR 4 -inv protein for 30 min at 22°C. Alternatively, RGDS peptide (Gibco, Breda, The Netherlands), or the monoclonal anti-␣ 5 ␤ 1 CD49e antibody (Serotec, Oxford, UK) and the recombinant soluble ␣ 3 ␤ 1 were used. 34 The treated cells were transferred to a 96-well plate coated with 12 g/ml fibronectin from human serum (Sigma-Aldrich) dissolved in PBS or with 2 g/ml invasin as described by Van Nhieu et al. 29 After incubation for 1 h at 37°C, the cells were washed twice with PBS and quantified by the crystal violet staining method. 38 The concentration that results in 30% inhibition (ID 30 ) was calculated from a dose-response curve, and used as a measure of affinity.
Transfection mixtures and measurements of the luciferase expression
For transfection experiments, HeLa or HEp-2 cells were seeded at a density of 2-3 × 10 4 cells per well in 24-well plates; transfection was performed the following day. Plasmid-protein-DOTAP complexes were prepared as follows: per well, 0.25 g of pCMVluc 26 was mixed with variable amounts (0-1 g) of (SPKR) 4 inv protein in 10 l, 10 mm Tris-HCl pH 7.5, 100 mm NaCl, 10% glycerol, 0.1% Tween-20. After 30 min at room temperature, different amounts (0-2 g) of DOTAP liposomes (BoehringerMannheim, Germany), diluted in Hepes buffered saline, were added. The complexes were left at room temperature for a further 30 min before being diluted in 0.2 ml medium without serum and antibiotics, and added to the cells. After 3-4 h incubation, the mixture was replaced by culture medium containing 10% fetal calf serum. After 35-48 h incubation, cells were lysed with 70 l lysis buffer (25 mm Tris-phosphate, pH 7.8, 10 g/l Triton-X 100, 1 mm DTT, 15% (v/v) glycerol) for 20 min at room temperature. Ten microliters of supernatant was assayed for luciferase activity as described. 39 Luciferase activity was expressed as relative light unit (RLU) per microgram of protein in the cell lysates. Protein concentration was determined with the BCA Protein assay (Pierce, Rockford, IL, USA).
Transfections of HeLa cells with polyethylenimine complexes were performed essentially as described above. All transfection experiments performed with polyethylenimine shown in this paper were performed in the absence of Tween-20. Titration with complexes made in the presence of Tween-20 resulted in comparable results (data not shown). Polyethylenimine (PEI, Aldrich; mw 23 000), extensively dialyzed against water and neutralized to pH 7.5, was diluted in phosphate-buffered saline (PBS). Plasmid DNA was diluted to 1 g per 80 l 10 mm Tris-HCl pH 7.5, 100 mm NaCl, 10% glycerol, to which the appropriate amount of (SPKR) 4 inv solubilized in the same buffer was added. After 30 min incubation at room temperature, an equal volume of PEI (0-3 g) in PBS was added to the concentration indicated. After a further 30 min incubation, the complexes were diluted in 800 l pre-warmed serum-free medium (DMEM/F10) and added to the cells (200 l per well, 3 × 10 4 cells). After 3-4 h, the mixture was replaced by culture medium containing 10% fetal calf serum. After 35-48 h incubation, cells were lysed and luciferase activity was determined as described above.
